Immunogenicity and protective efficacy of an anti-Streptococcus pyogenes vaccine candidate in multiple animal species
M Sheel - 2010 - eprints.qut.edu.au
Streptococcus pyogenes, also known as Group A Streptococcus (GAS) has been associated
with a range of diseases from the mild pharyngitis and pyoderma to more severe invasive …
with a range of diseases from the mild pharyngitis and pyoderma to more severe invasive …
Group A streptococcal vaccines: paving a path for accelerated development
JB Dale, VA Fischetti, JR Carapetis, AC Steer, S Sow… - Vaccine, 2013 - Elsevier
Group A streptococci (GAS) are important causes of morbidity and mortality worldwide.
These organisms cause a wide spectrum of disease, ranging from uncomplicated sore throat …
These organisms cause a wide spectrum of disease, ranging from uncomplicated sore throat …
Recent Scientific Advancements towards a Vaccine against Group A Streptococcus
J Fan, I Toth, RJ Stephenson - Vaccines, 2024 - mdpi.com
Group A Streptococcus (GAS), or Streptococcus pyogenes, is a gram-positive bacterium that
extensively colonises within the human host. GAS is responsible for causing a range of …
extensively colonises within the human host. GAS is responsible for causing a range of …
Correlates of Protection for M Protein‐Based Vaccines against Group A Streptococcus
SK Tsoi, PR Smeesters, HRC Frost… - Journal of …, 2015 - Wiley Online Library
Group A streptococcus (GAS) is known to cause a broad spectrum of illness, from
pharyngitis and impetigo, to autoimmune sequelae such as rheumatic heart disease, and …
pharyngitis and impetigo, to autoimmune sequelae such as rheumatic heart disease, and …
Progress in development of group A streptococcus vaccines
Y Song, X Zhang, C Lu, F Zhang… - Current pharmaceutical …, 2013 - ingentaconnect.com
Streptococcus pyogenes or Group A Streptococcus (GAS) is a major Gram-positive human
pathogen that causes diverse human diseases with a high morbidity and mortality …
pathogen that causes diverse human diseases with a high morbidity and mortality …
Vaccine development for group a streptococcus infections and associated diseases
Group A streptococcus (GAS) is responsible for a number of diseases ranging from
uncomplicated pharyngitis through to life-treating invasive and post-infectious diseases such …
uncomplicated pharyngitis through to life-treating invasive and post-infectious diseases such …
[HTML][HTML] Group A Streptococcus Infections: Their Mechanisms, Epidemiology, and Current Scope of Vaccines
Group A streptococci (GAS) are gram-positive, cocci-shaped bacteria that cause a wide
variety of infections and are a cause of significant health burden, particularly in lower-and …
variety of infections and are a cause of significant health burden, particularly in lower-and …
A multicomponent vaccine provides Immunity against local and systemic infections by group a Streptococcus across serotypes
S Bi, M Xu, Y Zhou, X Xing, A Shen, B Wang - MBio, 2019 - Am Soc Microbiol
Group A streptococcus (GAS) species are responsible for a broad spectrum of human
diseases, ranging from superficial to invasive infections, and are associated with …
diseases, ranging from superficial to invasive infections, and are associated with …
Group A streptococcal vaccine candidates: potential for the development of a human vaccine
Currently there is no commercial Group A Streptococcus (GAS; S. pyogenes) vaccine
available. The development of safe GAS vaccines is challenging, researchers are …
available. The development of safe GAS vaccines is challenging, researchers are …
Development of subunit vaccines for Group A Streptococcus
C Olive - Molecular Vaccines: From Prophylaxis to Therapy …, 2013 - Springer
There is currently no available vaccine to prevent infection with Streptococcus pyogenes
(also known as group A streptococcus, GAS), which can lead to the life-threatening diseases …
(also known as group A streptococcus, GAS), which can lead to the life-threatening diseases …